Search Results By Date:
Showing 31 - 45 of 111 results
  • Onitilo AA, Stankowski RV, Berg RL, Engel JM, Glurich IE, Williams G, Doi SA. R.. (2014 March). Type 2 diabetes mellitus, glycemic control, and cancer risk. EUROPEAN JOURNAL OF CANCER PREVENTION. 23(2):134-40.
    PubMed ID: 23962874
  • Onitilo AA, Stankowski RV, Berg RL, Engel JM, Glurich IE, Williams G, Doi SA. R.. (2014 March). Breast cancer incidence before and after diagnosis of type 2 diabetes mellitus in women: increased risk in the prediabetes phase. EUROPEAN JOURNAL OF CANCER PREVENTION. 23(2):76-83.
    PubMed ID: 23571511
  • Onitilo AA, Engel JM, Salzman-Scott SA, Stankowski RV, Doi SA. (2014). A core-item reviewer evaluation (CoRE) system for manuscript peer review. Account Res. 21(2):109-21.
    PubMed ID: 24228975
  • Onitilo AA, Berg RL, Engel JM, Stankowski RV, Glurich IE, Williams GA, Doi SA. R.. (2013 December). Prostate Cancer Risk in Pre-Diabetic Men: A Matched Cohort Study. Clinical Medicine & Research. 11(4):201-9.
    PubMed ID: 23656798
  • Onitilo AA, Berg RL, Engel JM, Glurich IE, Stankowski RV, Williams G, Doi SA. R.. (2013 August). Increased risk of colon cancer in men in the pre-diabetes phase. PLoS One. 8(8):E70426.
    PubMed ID: 23936428
  • Onitilo AA, Engel JM, Salzman-Scott SA, Stankowski RV, Doi SA. R.. (2013 June). Reliability of reviewer ratings in the manuscript peer review process: an opportunity for improvement. Account Res. 20(4):270-84.
    PubMed ID: 23805832
  • Glurich IE, Berg RL, Burmester JK. (2013 June). Does CALU SNP rs1043550 Contribute Variability to Therapeutic Warfarin Dosing Requirements? Clinical Medicine & Research. 11(2):73-9.
    PubMed ID: 23656803
  • Onitilo AA, Doi SA. R., Engel JM, Glurich IE, Berg RL. (2013 June). Relationship between Factor V Leiden mutation and venous thromboembolism in patients with breast cancer treated with tamoxifen. THROMBOSIS RESEARCH. 131(6):567-8.
    PubMed ID: 23497923
  • Onitilo AA, Kar P, Engel JM, Glurich IE. (2013 April). Long-Term Cardiac and Vascular Disease Outcomes Following Adjuvant Tamoxifen Therapy: Current Understanding of Impact on Physiology and Overall Survival, Minerva Medica. 104(2):141-53.
    PubMed ID: 23514990
  • Glurich IE, Chyou P, Engel JM, Cross DS, Onitilo AA. (2013 February). Tamoxifen-induced venothromboembolic events: exploring validation of putative genetic association. Clinical Medicine & Research. 11(1):16-25.
    PubMed ID: 23411630
  • Gullickson MEllen, Griesbach S, Folz CM, Knobloch MJ, Guenther SR. (2013 January). Development and Assessment of a Drug Interaction Curriculum for Medical Residents. Journal of Health-System Pharmacy Residents. 1(3):1-6.
  • Glurich IE, Acharya A, Shukla SK, Nycz G, Brilliant MH. (2013 January). The oral-systemic personalized medicine model at Marshfield Clinic. ORAL DISEASES. 19(1):1-17.
    PubMed ID: 22458294
  • Myklejord DJ, Yao L, Liang H, Glurich IE. (2012 October). Consensus guideline adoption for managing postoperative nausea and vomiting. WMJ. 111(5):207-13; quiz 214.
    PubMed ID: 23189453
  • Chowdhary R, Tan SL, Pavesi G, Jin J, Dong D, Mathur SK,...Bajic VB [including Glurich IE.] (2012 July). A database of annotated promoters of genes associated with common respiratory and related diseases. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY. 47(1):112-9.
    PubMed ID: 22383585
  • Onitilo AA, Engel JM, Glurich IE, Stankowski RV, Williams G, Doi SA. R.. (2012 July). Diabetes and cancer II: role of diabetes medications and influence of shared risk factors. CANCER CAUSES & CONTROL. 23(7):991-1008.
    PubMed ID: 22527174